RT Journal Article
SR Electronic
T1 Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001064
DO 10.1136/jitc-2020-001064
VO 8
IS 2
A1 Verschraegen, Claire F
A1 Jerusalem, Guy
A1 McClay, Edward F
A1 Iannotti, Nicholas
A1 Redfern, Charles H
A1 Bennouna, Jaafar
A1 Chen, Franklin L
A1 Kelly, Karen
A1 Mehnert, Janice
A1 Morris, John C
A1 Taylor, Matthew
A1 Spigel, David
A1 Wang, Ding
A1 Grote, Hans Juergen
A1 Zhou, Dongli
A1 Munshi, Neru
A1 Bajars, Marcis
A1 Gulley, James L
YR 2020
UL http://jitc.bmj.com/content/8/2/e001064.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.